MERCURY LABORATORIES
Back to Cashflow Statement
|
MERCURY LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.04 Cr | ₹-1.01 Cr | ₹-1.23 Cr | ₹-1.24 Cr | ₹-3.33 Cr |
What is the latest Cash Flow from Financing Activities ratio of MERCURY LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.04 Cr |
Mar2023 | ₹-1.01 Cr |
Mar2022 | ₹-1.23 Cr |
Mar2021 | ₹-1.24 Cr |
Mar2020 | ₹-3.33 Cr |
How is Cash Flow from Financing Activities of MERCURY LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.04 Cr | Negative | |
Mar2023 | ₹-1.01 Cr | Negative | |
Mar2022 | ₹-1.23 Cr | Negative | |
Mar2021 | ₹-1.24 Cr | Negative | |
Mar2020 | ₹-3.33 Cr | - |
Compare Cash Flow from Financing Activities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹103.5 Cr | -2.8% | -13.3% | -24.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -2.8% |
-13.3% |
-24.1% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses